Phasic dopamine responses to a food-predictive cue are suppressed by the glucagon-like peptide-1 receptor agonist Exendin-4

被引:35
|
作者
Konanur, Vaibhav R. [1 ]
Hsu, Ted M. [2 ]
Kanoski, Scott E. [3 ]
Hayes, Matthew R. [4 ]
Roitman, Mitchell F. [2 ]
机构
[1] Univ Illinois, Grad Program Neurosci, Chicago, IL USA
[2] Univ Illinois, Dept Psychol, 1007W Harrison St, Chicago, IL 60607 USA
[3] Univ Southern Calif, Dept Biol Sci, Human & Evolutionary Biol Sect, Los Angeles, CA 90007 USA
[4] Univ Penn, Dept Psychiat, Perelman Sch Med, Philadelphia, PA 19104 USA
关键词
Ventral tegmental area; Dopamine; Satiety; Reward; Motivation; Fiber photometry; VENTRAL TEGMENTAL AREA; NUCLEUS-ACCUMBENS; GLP-1; RECEPTORS; OPTOGENETIC EXCITATION; SUBJECTIVE VALUE; MEAL SIZE; RELEASE; NEURONS; REWARD; ACTIVATION;
D O I
10.1016/j.physbeh.2019.112771
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
Phasic dopamine activity is evoked by reliable predictors of food reward and plays a role in cue-triggered, goal-directed behavior. While this important signal is modulated by physiological state (e.g. hunger, satiety), the mechanisms by which physiological state is integrated by dopamine neurons is only beginning to be elucidated. Activation of central receptors for glucagon-like peptide-1 (GLP-1R) via long-acting agonists (e.g., Exendin-4) suppresses food intake and food-directed motivated behavior, in part, through action in regions with dopamine cell bodies, terminals, and/or neural populations that directly target the mesolimbic dopamine system. However, the effects of GLP-1R activation on cue-evoked, phasic dopamine signaling remain unknown. Here, in vivo fiber photometry was used to capture real-time signaling dynamics selectively from dopamine neurons in the ventral tegmental area of male and female transgenic (tyrosine hydroxylase-Cre; TH:Cre+) rats trained to associate an audio cue with the brief availability of a sucrose solution. Cue presentation evoked a brief spike in dopamine activity. Administration of Exendin-4 (Ex4; 0, 0.05, 0.1 mu g) to the lateral ventricle both dose-dependently suppressed sucrose-directed behaviors and the magnitude of cue-evoked dopamine activity. Moreover, the amplitude of cue evoked dopamine activity was significantly correlated with subsequent sucrose-directed behaviors. While female rats exhibited overall reduced dopamine responses to the sucrose-paired cue relative to males, there was no significant interaction with Ex4. Together, these findings support a role for central GLP-1Rs in modulating a form of dopamine signaling that influences approach behavior and provide a potential mechanism whereby GLP-1 suppresses food-directed behaviors.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] The glucagon-like peptide 1 receptor agonist Exendin-4 decreases relapse-like drinking in socially housed mice
    Thomsen, Morgane
    Dencker, Ditte
    Wortwein, Gitta
    Weikop, Pia
    Egecioglu, Emil
    Jerlhag, Elisabet
    Fink-Jensen, Anders
    Molander, Anna
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2017, 160 : 14 - 20
  • [2] Glucagon-like peptide-1 receptor agonist, exendin-4, reduces reinstatement of heroin-seeking behavior in rats
    Douton, Joaquin E.
    Augusto, Corinne
    Stoltzfus, Brooke
    Carkaci-Salli, Nurgul
    Vrana, Kent E.
    Grigson, Patricia S.
    BEHAVIOURAL PHARMACOLOGY, 2021, 32 (04): : 265 - 277
  • [3] Exendin-4, a glucagon-like peptide-1 receptor agonist, provides neuroprotection in mice transient focal cerebral ischemia
    Teramoto, Shinichiro
    Miyamoto, Nobukazu
    Yatomi, Kenji
    Tanaka, Yasutaka
    Oishi, Hidenori
    Arai, Hajime
    Hattori, Nobutaka
    Urabe, Takao
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2011, 31 (08) : 1696 - 1705
  • [4] Exendin-4, a glucagon-like peptide-1 receptor agonist, attenuates neointimal hyperplasia after vascular injury
    Hirata, Yoichiro
    Kurobe, Hirotsugu
    Nishio, Chika
    Tanaka, Kimie
    Fukuda, Daiju
    Uematsu, Etsuko
    Nishimoto, Sachiko
    Soeki, Takeshi
    Harada, Nagakatsu
    Sakaue, Hiroshi
    Kitagawa, Tetsuya
    Shimabukuro, Michio
    Nakaya, Yutaka
    Sata, Masataka
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2013, 699 (1-3) : 106 - 111
  • [5] Glucagon-Like Peptide-1 Agonist Exendin-4 Facilitates the Extinction of Cocaine-Induced Condition Place Preference
    Zhu, Changliang
    Hong, Tao
    Li, Hailiang
    Jiang, Shucai
    Guo, Baorui
    Wang, Lei
    Ding, Jiangwei
    Gao, Caibin
    Sun, Yu
    Sun, Tao
    Wang, Feng
    Wang, Yangyang
    Wan, Din
    FRONTIERS IN SYSTEMS NEUROSCIENCE, 2021, 15
  • [6] The glucagon-like peptide-1 receptor agonist, exendin-4, reduces sexual interaction behaviors in a brain site-specific manner in sexually naive male mice
    Vestlund, Jesper
    Jerlhag, Elisabet
    HORMONES AND BEHAVIOR, 2020, 124
  • [7] Glucagon-like peptide-1 receptor agonist exendin-4 mitigates lipopolysaccharide-induced inflammatory responses in RAW264.7 macrophages
    Lu, Canrong
    Xie, Tianyu
    Guo, Xin
    Wu, Di
    Li, Shuo
    Li, Xiongguang
    Lu, Yixun
    Wang, Xinxin
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, 77
  • [8] Acylation of the Incretin Peptide Exendin-4 Directly Impacts Glucagon-Like Peptide-1 Receptor Signaling and Trafficking
    Lucey, Maria
    Ashik, Tanyel
    Marzook, Amaara
    Wang, Yifan
    Goulding, Joelle
    Oishi, Atsuro
    Broichhagen, Johannes
    Hodson, David J.
    Minnion, James
    Elani, Yuval
    Jockers, Ralf
    Briddon, Stephen J.
    Bloom, Stephen R.
    Tomas, Alejandra
    Jones, Ben
    MOLECULAR PHARMACOLOGY, 2021, 100 (04) : 319 - 334
  • [9] Neuroprotective effect of the glucagon-like peptide-1 receptor agonist, synthetic exendin-4, in streptozotocin-induced diabetic rats
    Liu, Wei Jing
    Jin, Heung Yong
    Lee, Kyung Ae
    Xie, Shu Hua
    Baek, Hong Sun
    Park, Tae Sun
    BRITISH JOURNAL OF PHARMACOLOGY, 2011, 164 (05) : 1410 - 1420
  • [10] Treatment with Glucagon-Like Peptide-1 Agonist Exendin-4 in a Patient with Hypothalamic Obesity Secondary to Intracranial Tumor
    Simmons, Jill H.
    Shoemaker, Ashley H.
    Roth, Christian L.
    HORMONE RESEARCH IN PAEDIATRICS, 2012, 78 (01): : 54 - 58